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292Introduction: Intraoperative flowmetric results of different configurations (Y-graft or aorta–coronary) of radial
artery grafts have been poorly investigated.
Methods:We report the results of an observational study designed to analyze transit-time flow measurements at
baseline and during 1:1 intra-aortic balloon pumping in 114 consecutive patients receiving the radial artery as
a aorta–coronary bypass (group A, 72 patients) or as a Y-graft with the left internal thoracic artery (group B,
42 patients). Graft flow reserve, recruited by 1:1 intra-aortic balloon pumping) greater than 1 indicated recruit-
ment of surplus graft flow. Results were stratified by grafted territory and surgical technique.
Results: Hospital outcome was comparable. Baseline transit-time flow results were similar between the 2 groups
in terms of maximum diastolic flow, minimum systolic flow, mean flow, and pulsatility index. Graft flow reserve
was not recruited by intra-aortic balloon pumping in 3 (2.7%) malfunctioning single aorta–oronary radial artery
bypass grafts (P ¼ .005 versus successful radial artery bypass grafts). Graft flow reserve was recruited (>1) by
intra-aortic balloon pumping in the remaining 111 patent radial artery bypass grafts. Y-grafts showed higher max-
imum diastolic flow P<.0001), mean flow (P<.0001), graft flow reserve (P<.0001), percentage improvement
of maximum diastolic flow (P<.0001), and of mean flow (P<.0001) compared with aorta–coronary radial artery
bypass grafts. These results were confirmed for the right coronary (P  .004) and the circumflex territory (P 
.001), for off-pump (P  .008) or cardiopulmonary bypass (P< .0001) and for patients undergoing isolated by-
pass grafting (P< .0001).
Conclusions: Intraoperative flows of radial artery bypass grafts showed comparable baseline results in single
aorta–coronary conduits and Y-grafts. Graft flow reserve recruited by intra-aortic balloon pumping was higher
in Y-conduits, regardless of the grafted territory and the perfusion strategy chosen. Failed radial artery bypass
grafts did not improve transit-time flow results during 1:1 intra-aortic balloong pumping nor showed any recruit-
ment of graft flow reserve. (J Thorac Cardiovasc Surg 2010;140:292-7)Supplemental material is available online.
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The recent demonstration of improved survival in patients
undergoing arterial revascularization stimulated surgeons
to an increasing use of arterial grafts other than internal tho-
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The Journal of Thoracic and Cardiovascular SurgIn this setting, the radial artery (RA) is the most frequently
used arterial conduit worldwide.1 Different configurations
of RAs as conduits for myocardial revascularization have
been reported.2 However, despite comparable clinical out-
comes, few studies have addressed the in vivo functional
flowmetric behavior of different surgical configurations.2
In particular, the recent availability of transit-time flowmetry
(TTF) has allowed surgeons to explore in vivo the functional
behavior of different conduits.3,4 Moreover, the correlation
between TTF results and graft patency at short-term angio-
graphic follow-up has popularized the use of TTF technol-
ogy in daily practice.4
Furthermore, despite previous concerns that have arisen
toward the appropriateness of a single blood supply through
other arterial conduits in composite configurations, it has
been clearly demonstrated that the main stem of an ITA sup-
plies sufficient blood in composite Y- or T-graft configura-
tions.5 However, the literature lacks studies reporting the in
vivo amount of blood flowing through the 2 different
branches of composite grafts with RAs. Moreover, although
comparable blood flow has been reported in composite graftsery c August 2010
Abbreviations and Acronyms
CABG ¼ coronary artery bypass graft
CPB ¼ cardiopulmonary bypass
GRF ¼ graft flow reserve
IABP ¼ intra-aortic balloon pump
ITA ¼ internal thoracic artery
LAD ¼ left anterior descending coronary
artery
LITA ¼ left internal thoracic artery
OPCABG ¼ off-pump coronary artery bypass
grafting
PI ¼ pulsatility index
RA ¼ radial artery
TTF ¼ transit-time flowmetry
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knowledge no literature data have ever addressed differences
in flowmetric results of the RA in coronary artery bypass
grafting (CABG) when used as single aorta–coronary con-
duits or as composite Y-grafts; similarly, no stratification
of TTF results based on the grafted territory and the surgical
technique used (off-pump/on-pump) has ever been reported.
Therefore, the aim of the present observational study was
to investigate TTF results of RA CABGs in 2 different con-
figurations (single aorta–coronary [(group A] or composite
Y-graft with left ITA [LITA; group B], in different target ter-
ritories, either off-pump (OPCABG) or on cardiopulmonary
bypass (CPB), during a 16-month period at a single aca-
demic institution.PATIENTS AND METHODS
Patients
We analyzed data from 114 consecutive patients undergoing CABGwith
preoperative intra-aortic balloon pump (IABP) support at our institution
during the past 16 months (January 2008–May 2009). Seventy-two patients
(group A) underwent aorta–coronary RA CABG, the remaining 42 (group
B) underwent composite Y-graft with RA and LITA. All patients received
preoperative IABP, according to institutional policy.4 The study protocol
was approved by the institution’s ethical committee/institutional review
board, and informed consent was obtained from each patient.
Surgical Technique
To better support hemodynamic function before CABG, institutional pol-
icy called for percutaneous insertion of an IABP with the technique already
described.4 Surgery was performed through a median sternotomy by the
same surgeons (A.R., F.O.). Harvesting of the LITA and RA has been stan-
dardized and already reported in the literature.3 In brief, the composite
LITA-RA anastomoses were performed in advance, after systemic heparin-
ization. The RA was spatulated 2 mm and anastomosed to a 4- to 5-mm in-
cision in the pleural aspect of the LITA at the level where the LITA enters the
pericardial space anterior to the left atrial appendage. Obtuse marginal
branches and the right coronary territory were the targets of RA grafts. Distal
anastomoses were performed with 8-0 polypropylene stitches. Intravenous
or oral vasodilators, except for enoximone infusion, were never used after
RA grafting. So that the risk for ‘‘string sign’’ and/or competitive flowThe Journal of Thoracic and Cafrom the native coronary circulation could be avoided, RA grafting was
only accomplished on target vessels with more than 80% stenosis at least.
The choice for aorta–coronary conduit configuration or for the Y-configura-
tion was left to surgeon’s choice, except in 4 (3.5%) patients with diffuse
calcifications of the ascending aorta and 1 (0.8%) patient with ‘‘egg-shell’’
aorta, in whom composite Y-grafting was considered mandatory. Proximal
anastomoses of all RA grafts were directly done on the ascending aorta. The
use of CPB and OPCABG protocols was standardized.3 Both surgeons were
able to perform either traditional or Y-conduit grafts.
Flowmetric Analysis and Evaluation of Graft Flow
Reserve
Graft flowmetry was evaluated during IABP support and during its tem-
porary cessation to avoid intraoperative bias and to standardize the technique.
Thus patients served as their own controls. Graft functionwas assessed under
stable hemodynamic conditions, generally 30 minutes after protamine ad-
ministration. Considering that graft flow reserve (GFR) is also influenced
by loading conditions, TTF analysis was performed under similar volume
loading (central venous pressure: group A 9.7  2.4 mm Hg vs group B
10.2  1.9 mm Hg; P ¼ .689). Flowmetry of the grafts was performed
with a transit-time flowmeter (HT313 Transonic; Transonic Systems Inc,
Ithaca, NY). Different probe sizes (2, 2.5, or 3 mm) were available to avoid
distortion or compression of grafts. Skeletonization of a small segment of the
proximal RA branch and of the proximal LITA branch was necessary to re-
duce the quantity of tissue interposed between the vessel and the probe.
The curves were always coupled with the electrocardiogram tracing to
differentiate systolic from diastolic flow. The following variables were
calculated—maximum diastolic, minimum systolic, and mean flows
(expressed inmL/min)—directly derived from the flowmeter, and pulsatility
index (PI, derived from maximum diastolic flowminimum systolic flow/
mean flow). The flow pattern (systolic, diastolic) was directly derived from
the flow curve of the trace. Data from LITA and RA conduits, stratified
by grafted territory (circumflex and right coronary) and surgical technique
(OPCABG/CPB) were recorded. So that the potential of IABP to recruit
GFR could be evaluated, TTF measurements were recorded both during
1:1 IABP support and after 5 minutes of temporary cessation (‘‘IABP
off’’). Systolic, end-diastolic, and mean arterial pressures were recorded in-
vasively through a pressure transducer connected to the RA and compared
during 1:1 IABP support and during its temporary cessation. Percent im-
provements in maximum diastolic, minimum systolic, and mean blood
flows were calculated. The GFR was calculated from the mean flow occur-
ring during 1:1 IABP support divided by the mean flow during temporary
cessation, as already reported.3
Data Collection
According to an institutional policy, inotropes were started immediately
either in on-pump CABG or in OPCABG, starting with enoximone at a dos-
age of 5 mg $ kg1 $ min1 in respect with the protocol already reported.7
Troponin I from the peripheral venous line was collected preoperatively
and on the first and second postoperative days.
Hospital mortality and morbidity were defined as previously reported.3,7
Statistical Analysis
All data were prospectively recorded by means of the institutional data-
base. Statistical analysis was performed with use of the SPSS program for
Windows, version 13.0 (SPSS Inc, Chicago, Ill). Continuous variables are
presented as means standard deviation, and categorical variables are pre-
sented as number (percentage) of patients. Data were checked for normality
before analysis. The paired-sample t test was used to evaluate differences in
continuous variables during 1:1 IABP support versus during its temporary
cessation (‘‘IABP-off’’). One-way analysis of variance was used to evaluate
the significance of differences among types of bypass grafts. Two-way anal-
ysis of variance for repeated measures was used for comparisons within (1:1rdiovascular Surgery c Volume 140, Number 2 293
TABLE 1. TTF results during 1:1 IABP and during temporary IABP
discontinuation, by type of bypass graft
IABP D/C 1:1 IABP Py Pz
RA CABGs
Maximum diastolic flow
Group A (69 patients) 67.9  16.9 86.7  25.2 .0001 .0001
Group B (42 patients) 67.4  11.4 136.5  25.4 .0001
P* .284 .0001 —
Mean flow
Group A (69 patients) 35.9  10.9 48.9  15.2 .0001 .0001
Group B (42 patients) 36.5  9.5 72.7  19.9 .0001
P* .709 .0001 —
Minimum systolic flow
Group A (69 patients) 9.8  7.0 8.6  7.8 .445 .206
Group B (42 patients) 10.9  8.3 9.9  8.0 .473
P* .285 .025 —
Pulsatility index
Group A (69 patients) 2.3  1.0 3.0  0.8 .0001 .863
Group B (42 patients) 1.8  0.5 3.5  0.5 .0001
P* .065 .0001 —
LITA-LAD
Maximum diastolic flow
Group A (69 patients) 68.9  32.3 128.2  50.6 .0001 .885
Group B (42 patients) 66.8  35.2 125.3  55.8 .0001
P* .986 .869 —
Mean flow
Group A (69 patients) 34.1  21.4 57.0  31.1 .0001 .848
Group B (42 patients) 32.9  25.6 57.2  34.8 .0001
P* .967 .973 —
Minimum systolic flow
Group A (69 patients) 6.8  0.4 7.9  1.0 .328 .967
Group B (42 patients) 6.5  0.6 8.1  1.1 .299
P* .945 .831 —
Pulsatility index
Group A (69 patients) 2.2  0.5 3.4  1.2 .0001 .909
Group B (42 patients) 2.1  0.4 3.5  0.8 .0001
P* .896 .946 —
TTF, Transit-time flowmetry; IABP, intra-aortic balloon pump;D/C, discontinued; RA,
radial artery; CABG, coronary artery bypass graft; LITA, left internal thoracic artery;
LAD, left anterior descending. *P value for the comparison of flows at baseline and
during IABP 1:1; yP value for comparison of flows within groups; zP value for com-
parison of flows between groups.
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DIABP versus ‘‘IABP-off’’) and between groups (group A vs group B, nor-
mal-functioning versus failed grafts). Categorical variables were analyzed
with the use of either the c2 test or Fisher’s exact test.RESULTS
Hospital Outcome
The 2 groups proved homogeneous for preoperative vari-
ables (Table E1). Similarly, no differences were recorded for
intraoperative variables (Table E1) or for perioperative tro-
ponin I leakage and for the need for perioperative inotropic
support (Table E2). Three (2.6%) patients died during hos-
pitalization, because of perioperative acute myocardial in-
farction (n ¼ 1), stroke (n ¼ 1), and multiorgan failure
after pneumonia (n ¼ 1). However, no differences were de-294 The Journal of Thoracic and Cardiovascular Surgtected in hospital mortality between the 2 groups (group A:
2/72 [2.8%] vs group B 1/42 [2.4%]; P ¼ .694). Similarly,
the 2 groups were comparable for postoperative complica-
tion rate (perioperative acute myocardial infarction group
A/group B 0/1; P ¼ .368; low output syndrome group A/
group B 0/1; P ¼ .368; acute renal failure group A/group
B 2/1; P ¼ .694; acute respiratory failure group A/group B
8/4; P¼ .529; stroke group A/group B 1/1; P¼ .603), giving
a global morbidity rate of 13.9% in group A versus 11.9%
in group B (P ¼ .502). Finally, there were neither major nor
minor IABP-related complications during the study period.
TTF Analysis and GFR
There were 3 cases of failed CABG (all of them were
aorta–coronary grafts), one of which was responsible for
perioperative myocardial infarction (Table 1). Among these
grafts, the maximum diastolic, minimum systolic, and the
mean blood flow rates were significantly lower than those
among normally functioning grafts. Moreover, the failed
grafts did not show improvement of blood flow during 1:1
IABP and a corresponding lack of GFR. In all these patients,
the detection of poor TTF findings was associated with cor-
responding ischemic electrocardiographic and/or echocar-
diographic signs (new akinetic or hypokinetic segments)
of the corresponding myocardial territories. Two patients
of these 3 cases of failed CABG had good distal vessel qual-
ity at preoperative coronary angiography that could not ex-
plain the unsatisfactory poor TTF results. Therefore, in
these 2 cases, the distal anastomoses have been redone.
However, to avoid intraoperative bias, these 3 cases were
excluded from the study.
Therefore, the results reported describe the TTF analysis
performed on 111 functioning grafts (group A¼ 69 patients;
group B ¼ 42 patients). When TTF results were analyzed
during temporary IABP cessation (‘‘baseline’’ values), no
differences were recorded between the 2 groups in terms
of maximum diastolic flow, minimum systolic flow, mean
flow, and PI when the 2 different RA CABG configurations
were tested (Table 1); similarly, no differences were re-
corded when the LITA–left anterior descending (LAD) graft
was tested under baseline condition. However, maximum di-
astolic flow, mean flow, and PI significantly improved dur-
ing IABP assistance in LITA-LAD and in the 2 different
RA CABG constructions, although such increment of flow
was significantly higher in Y-graft configuration than in sin-
gle aorta–coronary configuration for RA CABGs (Table 1).
However, no difference in LITA-LAD flowwas detected be-
tween the 2 groups when 1:1 IABP assistance was employed
(Table 1). GFR was recruited (>1) during 1:1 IABP in all
111 normally functioning RA grafts, although significantly
higher GFR was noted in Y-RA CABG compared with sin-
gle aorta–coronary CABG (Table 2). Similar results were
evidenced when percent improvements of maximum dia-
stolic flow and of mean flow were computed (Table 2).ery c August 2010
TABLE 2. GFR and percent improvement of maximum diastolic and
mean flows by type of bypass graft
Variables
Group A
(69 patients)
Group B
(42 patients) P
GFR 1.37  0.15 1.99  0.18 .0001
Maximum
diastolic flow
improvement,%
(95% CI)
27.8%
(7.3%–62.0%)
102.6%
(57.7%–155.2%)
.0001
Mean flow
improvement,%
(95% CI)
37.4%
(14.8%–89.4%)
99.2%
(43.9%–121.6%)
.0001
GFR, Graft flow reserve; CI, confidence interval.
TABLE 3. TTF results during 1:1 IABP and during temporary IABP
discontinuation, excluding patients undergoing procedures other than
myocardial revascularization
IABP D/C 1:1 IABP Py Pz
RA CABGs
Maximum diastolic flow
Group A (35 patients) 68.6  12.2 84.1  14.4 .0001 .0001
Group B (21 patients) 70.6  9.9 141.3  23.1 .0001
P* .234 .0001 —
Mean flow
Group A (35 patients) 36.7  8.1 47.7  9.8 .0001 .0001
Group B (21 patients) 37.5  8.0 74.1  17.1 .0001
P* .366 .0001 —
Minimum systolic flow
Group A (35 patients) 8.5  6.6 13.3  9.2 .0001 .079
Group B (21 patients) 9.0  6.9 21.4  13.6 .0001
P* .688 .0005 —
Pulsatility index
Group A (35 patients) 1.8  0.6 2.7  0.6 .0001 .047
Group B (21 patients) 1.7  0.6 3.4  0.6 .0001
P* .505 .0001 —
GFR
Group A (35 patients) 1.3  0.1 .0001
Group B (21 patients) 2.0  0.2
TTF, Transit-time flowmetry; IABP, intra-aortic balloon pump;D/C, discontinued; RA,
radial artery; CABG, coronary artery bypass graft; GFR, graft flow reserve. *P value
for the comparison of flows at baseline and during IABP 1:1; yP value for comparison
of flows within groups; zP value for comparison of flows between groups.
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the same systolic arterial pressures during either 1:1 IABP or
IABP cessation (108.5 28.4 mmHg and 107.7 24.3 mm
Hg, respectively; P ¼ .314), the maximum diastolic and
mean flows on TTF analysis were higher during 1:1 IABP
support versus IABP cessation, regardless of the presence
of statistically significant lower end-diastolic and mean arte-
rial pressures (end-diastolic pressure during TTF, 60.5 
22.2 mm Hg during 1:1 IABP vs 67.9 20.2 mm Hg during
IABP cessation; P< .001; mean arterial pressure during
TTF, 70.9  10.3 mm Hg during 1:1 IABP vs 83.2  9.9
mm Hg during IABP cessation; P<.001). However, no dif-
ferences were recorded in the 2 groupswhen systolic, end-di-
astolic, and mean arterial pressures were considered during
both 1:1 IABP and its cessation (systolic arterial pressure
P ¼ .772; end-diastolic arterial pressure P ¼ .698; mean
arterial pressure P ¼ .611).
When TTF results of RA CABGs were further stratified
for the perfusion strategy (‘‘off-pump’’ or ‘‘on-pump,’’
Table E3) or grafted territory (circumflex or right coronary
territory, Table E4), a significantly higher maximum dia-
stolic flow, mean flow, and GFR during 1:1 IABP were
confirmed whenever Y-graft construction was preferred to
single aorta–coronary RA grafts.
These results were also confirmed, either in terms of flow-
metry or in terms of GFR, when patients with associated pro-
cedures were excluded from the analysis (Table 3).
DISCUSSION
Exclusive use of arterial conduits to achieve coronary
revascularization is a potential solution for the late failure
of saphenous vein grafts.2,8 Since the reintroduction of the
RA in daily surgical practice,9 several studies have demon-
strated the safety and effectiveness of RA CABG as the sec-
ond conduit after ITAs.1,2 In the quest to perform routine total
arterial revascularization, composite Y-graft methods are
gaining popularity.2,8 However, whether the LITA is suffi-
cient or not to provide adequate blood flow to all grafted ter-
ritories is still debated.8 Even though some reports proved the
effectiveness of composite arterial conduits,5 few studies ad-The Journal of Thoracic and Cadressed the functional in vivo behavior of these conduits.
Furthermore, no studies compared flowmetric results of com-
posite Y-grafts with those of single aorta–coronary conduits,
nor did they evaluate the GFR of these 2 surgical techniques.
TTF technology gave the possibility to investigate the func-
tional behavior of CABG, as well as to anticipate the angio-
graphic patency.4,10,11 Accordingly, our group has recently
demonstrated the ability of TTFmeasurements to investigate,
during 1:1 IABP, the GFR of different conduits.3
Our results confirmed previous findings proving the ap-
propriateness of blood supply with the composite configura-
tion. Baseline maximum diastolic flow, mean flow,
minimum systolic flow, and PI were comparable with either
aorta–coronary or Y-configuration (Tables 1 to 3 and E1 to
E3). Furthermore, the composite configuration did not affect
the graft flow of the LITA limb, as demonstrated by the sim-
ilar TTF findings. These data confirm those of Affleck and
coworkers,6 showing excellent graft flow of composite
LITA-RA T-grafts.
According to the institutional policy to use RA only on se-
verely diseased (>80% stenosis) coronary arteries, our data
are in line with those of Markwirth and associates,12 show-
ing higher Y-conduit flows in cases of severe stenosis of the
grafted coronary artery, and of Desai and coworkers,13 sup-
porting the need for accurate choice of target vessels in cases
of composite grafts.rdiovascular Surgery c Volume 140, Number 2 295
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associated with higher GRF of RA limb compared with
the isolated aorta–coronary configuration. Moreover, these
data support the use of Y-conduits to assure higher coronary
flow reserve.12
Our results could reflect the different biological properties
of the SRAandLITA.He andLiu14 reported higher release of
nitric oxide by the LITA compared with the RA. Moreover,
the latter conduit exhibits greater contraction to chemical
stimulation than does the LITA,15 and this higher vasoreac-
tivity could affect the long-term graft patency.2,14,15
It could be speculated that the site of proximal anastomo-
sis could influence graft function. In fact, in aorta–coronary
RA CABG, the RA behavior relies totally on its biological
properties. On the other hand, in Y-conduits, the LITA could
modulate the side-branch conduit function. Accordingly,
Tarr and coworkers16 recently described the possibility for
a paracrine effect of LITA on the nearest endothelium of
the anastomosed vessel.
A recent cornerstone paper by Kahn and colleagues17
showed lower graft patency at short-term follow-up after
OPCABG compared with on-pump CABG. However, the
long-term patency is affected critically by the genetically
modulated atherosclerotic process,18 which is in a reverse re-
lationship with the flow rate throughout the graft itself.19 On
the other hand, the short-term patency critically depends on
technical accuracy, which can be investigated by TTF.3,4
However, our TTF analysis confirms our previous findings
showing that perioperative patency is not influenced by the
off-pump technique. Moreover, the reported higher GFR of
the Y-conduit is confirmed regardless the perfusion strategy.
Although the efficacy of IABP has been extensively dem-
onstrated, the effects of IABP on CABG flow remain uncer-
tain.20 In particular, Meyns and coworkers21 showed, in an
animal model, that blood flow was improved in both ITA
and venous conduits when IABP was placed in the ascend-
ing aorta, but not when placed in the descending aorta. Ta-
kami and Masumoto22 proved in humans that the degree
of increase is greater in the in situ LITA supplying the
LAD artery than in aorta–coronary grafts anastomosed to
other coronary arteries. We confirm here that IABP can in-
crease diastolic and mean CABG flow with no increase in
mean systemic arterial pressure,3 either in the LITA or in
the RA. These data could suggest that the augmented dia-
stolic pressure, in association with the systolic unloading,
is responsible for the increased flow with IABP. Although
these data may also be related to the proximity of the
IABP and the subclavian artery (proportionately greater aug-
mented flow for composite compared with aorta–coronary
RA grafts), certainly more studies are needed to further clar-
ify these topics.
Despite our data conflict with those of Tsuchida,23 Ki-
mura,24 and their associates, who noted that IABP was not
associated with improved coronary flow distal to sites of ste-296 The Journal of Thoracic and Cardiovascular Surgnosis, our results can be ascribed to the fact that normally
functioning CABG would, by definition, circumvent me-
chanical obstructions to coronary flow caused by stenosis.
Definitely more studies with pressure–volume loops are nec-
essary to better address this topic, especially in experimental
animal models.
These results could suggest the use of IABP for patients
with arterial grafting with evidence of hypoperfusion syn-
drome. Mechanistically, these results also suggest that
LITA can adapt quickly to accommodate large increases in
flow, whereas the proximal aortic anastomosis of the RA
may not be able to respond quantitatively to the same degree.
Accordingly, our TTF findings support extending the indica-
tion for Y-grafts, beyond that of the generally accepted por-
celain/severely diseased aorta. However, our results are
consequential to our policy of a more liberal use of IABP
and may not be in accordance with that of other surgeons
in the methodology of the study and of our clinical and sur-
gical practice.
It is not clear that similar results would occur in other clin-
ical scenarios, such as during exercise or under pharmaco-
logic stress. Intraoperative pharmacologic tests using
either dobutamine or adenosine are widely established
methods to evaluate graft function. However, the chrono-
tropic response to dobutamine or the potential hypotension
after adenosine administration can impair the hemodynam-
ics of an ischemic patient. On the other hand, IABP helps
to ‘‘stabilize’’ the hemodynamic status. Moreover, we
have already demonstrated IABP as an alternative tool to in-
vestigate GFR.3,7 Moreover, the peculiar changes of TTF re-
sulting in functioning and malfunctioning grafts with and
without IABP support suggest TTF analysis during IABP as-
sistance 1:1 as a useful adjunct to the clinical practice when-
ever an IABP is still in place.
We therefore conclude that baseline TTF results of single
aorta–coronary RA CABGs are comparable with those of
composite LITA-RA Y-grafts. However, IABP-induced
GFR was more highly recruited in composite Y-conduits
than in aorta–coronary CABG, regardless of the grafted ter-
ritory and the perfusion strategy. In our opinion, TTF anal-
ysis should be routinely employed during coronary
surgery as a satisfactory instrument for intraoperative graft
surveillance. Moreover, the combination of IABP and TTF
technology can help in early detection of malfunctioning
RA grafts through demonstration of poor baseline TTF re-
sults and the absent recruitment of GFR.
A major limitation of the study is the absence of a system-
atic angiographic control in the 2 groups. Obviously, angi-
ography is still the gold standard method to detect graft
patency25; however, TTF analysis has been introduced in
the surgical armamentarium as an intraoperative diagnostic
tool. Several reports comparing TTF and coronary angiogra-
phy demonstrated that intraoperative TTF results correlate
with angiography at short- and midterm follow-up.4,10,11ery c August 2010
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intraoperative factors. Accordingly, we tried to standardize
the intraoperative analysis also using each patient as his or
her own ‘‘control’’ to minimize such bias.3
Another limitation of the study is the lack of a properly de-
signed investigation to ascertain differences between TTF
results among patients undergoing CABG on-pump versus
off-pump. However, some reports confirmed that TTF is
a valuable tool in determining coronary graft patency after
CABG either with or without CPB.10 Accordingly, analysis
of the OPCABG subgroup further confirmed the results that
we found among the whole patient population analyzed in
the present study.References
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TABLE E1. Preoperative and intraoperative variables
Variables
Group A
(72 patients)
Group B
(42 patients) P value
Age 67.5  6.6 66.9  6.7 .679
Male sex 66 (91.7%) 39 (92.9%) .563
Diabetes mellitus 47 (65.3%) 25 (59.5%) .338
Hypertension 58 (80.6%) 32 (76.2%) .373
COPD 49 (68.1%) 29 (69.0%) .542
Dyslipidemia 44 (61.1%) 26 (61.9%) .547
Acute MI (<4 wk) 36 (50.0%) 22 (52.4%) .480
Subacute MI 22 (30.6%) 12 (28.6%) .499
LMSD 19 (26.4%) 16 (38.1%) .137
LVEF<30% 9 (12.5%) 8 (19.0%) .248
LVEF 30%–50% 52 (72.2%) 27 (64.3%) .249
LVEF>50% 11 (15.3%) 7 (16.7%) .521
TIMI LAD 0.7  0.6 0.6  0.7 .484
TIMI CX 0.6  0.5 0.7  0.5 .387
TIMI RX 0.9  0.7 1.0  0.7 .496
No. CABG/patients 3.2  0.5 3.4  0.7 .089
OPCABG 24 (33.3%) 15 (35.7%) .476
CPB CABG 48 (66.7%) 27 (64.3%) .476
ACC time (min) 49.2  5.7 48.8  5.6 .829
CPB time (min) 85.2  13.1 90.8  14.7 .099
Total arterial CABG 12 (16.7%) 12 (28.6%) .104
Associated mitral surgery 22 (30.6%) 14 (33.3%) .458
Associated aortic valve
surgery
6 (8.3%) 5 (11.9%) .377
Asociated SVR 7 (9.7%) 3 (7.1%) .460
COPD, Chronic obstructive pulmonary disease;MI,myocardial infarction; LMSD, left
main stem disease; LVEF, left ventricular ejection fraction; TIMI, Thrombolysis In
Myocardial Infarction; LAD, left anterior descending; CX, circumflex artery; RX, right
coronary artery; CABG, coronary artery bypass grafting;OPCABG, off-pump surgery;
CPB CABG, CABG on cardiopulmonary bypass; ACC, aortic crossclamping; CPB,
cardiopulmonary bypass; SVR, surgical ventricular restoration.
TABLE E2. Troponine leakage and doses of inotropes
Group A
(72 patients)
Group B
(42 patients) P value
Troponin I (mg/L)
Preoperative 0.32  0.20 0.30  0.21 .696
First day 0.87  0.24 0.94  0.34 .186
Second day 1.62  0.35 1.55  0.36 .350
Inotropic support, No.
(%)]
Low dose 60/72 (83.3%) 32/42 (76.2%) .244
Medium dose 11/72 (15.3%) 9/42 (21.4%) .279
High dose 1/72 (1.4%) 1/42 (2.4%) .603
TABLE E3. TTF results of well-functioning RA CABG by surgical
technique
IABP D/C 1:1 IABP Py Pz
CPB-CABG
Maximum diastolic
flow
GroupA (46 patients) 67.3  17.2 86.4  24.8 .0001 .0001
Group B (27 patients) 68.2  10.5 137.1  22.6 .0001
P* .677 .0001
Mean flow
GroupA (46 patients) 35.9  11.9 48.2  15.8 .0001 .0001
Group B (27 patients) 35.9  8.3 71.7  17.2 .0001
P* .560 .0001
Pulsatility index
GroupA (46 patients) 2.3  1.0 3.1  0.8 .0001 .952
Group B (27 patients) 1.9  0.5 3.5  0.6 .0001
P* .154 .001
GFR 1.3  0.2 2.0  0.2 .0001
OPCABG
Maximum diastolic
flow
GroupA (23 patients) 69.2  16.5 65.8  13.2 .0001 .003
Group B (15 patients) 87.4  26.3 135.3  30.6 .0001
P* .230 .0001
Mean flow
GroupA (23 patients) 35.8  8.5 37.6  11.6 .0001 .008
Group B (15 patients) 50.3  14.1 74.4  24.7 .0001
P* .842 .0001
Pulsatility index
GroupA (23 patients) 2.2  1.1 1.7  0.3 .0001 .817
Group B (15 patients) 2.8  0.9 3.5  0.4 .0001
P* .243 .0001
GFR 1.4  0.2 1.9  0.2 .0001
TTF, Transit-time flowmetry; RA, radial artery; CABG, coronary artery bypass graft-
ing; IABP, intra-aortic balloon pumping; D/C, discontinued; CPB, cardiopulmonary
bypass; GFR, graft flow reserve; OPCABG, off-pump CABG. *P value for the com-
parison of flows at baseline and during IABP 1:1; yP value for comparison of flows
within groups; zP value for comparison of flows between groups
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TABLE E4. TTF results of well-functioning RA CABG by grafted
territory
IABP D/C 1:1 IABP Py Pz
RX
Maximum diastolic
flow
GroupA (29 patients) 67.2  18.5 86.1  27.1 .0001 .0001
Group B (17 patients) 68.4  11.4 141.9  26.4 .0001
P* .555 .0001
Mean flow
GroupA (29 patients) 33.6  10.6 46.8  16.4 .0001 .004
Group B (17 patients) 35.0  9.0 70.0  18.6 .0001
P* .812 .0001
Pulsatility index
GroupA (29 patients) 2.4  1.3 3.1  1.1 .0001 .775
Group B (17 patients) 1.8  0.4 3.6  0.5 .0001
P* .127 .0001
GFR
GroupA (29 patients) 1.4  0.2 .0001
Group B (17 patients) 2.0  0.2
CX
Maximum diastolic
flow
GroupA (40 patients) 68.6  15.8 87.2  23.4 .0001 .0001
Group B (25 patients) 66.7  11.7 132.7  24.6 .0001
P* .381 .0001
Mean flow
GroupA (40 patients) 37.6  10.8 50.5  14.3 .0001 .001
Group B (25 patients) 37.5  9.8 74.6  20.9 .0001
P* .751 .0001
Pulsatility index
GroupA (40 patients) 2.2  0.8 2.9  0.6 .0001 .531
Group B (25 patients) 1.9  0.5 3.5  0.6 .0001
P* .299 .0001
GFR
GroupA (40 patients) 1.3  0.2 .0001
Group B (25 patients) 1.9  0.2
TTF, Transit-time flowmetry; RA, radial artery; CABG, coronary artery bypass graft-
ing; IABP, intra-aortic balloon pumping; D/C, discontinued; RX, right coronary terri-
tory; CX, circumflex coronary territory; GFR, graft flow reserve. *P value for the
comparison of flows at baseline and during IABP 1:1; yP value for comparison of
flows within groups; zP value for comparison of flows between groups
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